Latest News

Senators Reintroduce Bill Prohibiting Sale of Candy-Flavored Weed Products to Minors

(Washington, DC) —Last week, Senator Chuck Grassley (R-IA) reintroduced a bill (S.4628) which SAM helped to draft in 2017 that prohibits the sale of candy-flavored marijuana products to minors. The bill has 25 cosponsors. The introduction follows recent warning letters from the FDA on copycat pot products and letters to Congress from famous brands like Pepsi […]

SAM-Drafted Marijuana Research Bill Passes House of Representatives

(Washington, DC) — Today, The House of Representatives passed the groundbreaking, bipartisan Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454) by a 325-95 vote. This legislation is the most significant advancement in marijuana research reform in several years. The bill, which SAM helped draft and has supported for several years, streamlines the application process […]

Cannabis Administration and Opportunity Act Introduced in the Senate

(Washington, DC) Today, Senators Booker, Schumer, and Wyden introduced the Cannabis Administration and Opportunity Act (CAOA), a bill that would legalize and commercialize marijuana nationwide. “The Cannabis Administration and Opportunity Act marches forward on unchecked marijuana legalization, despite the challenges plaguing states with legal weed,” said Kevin Sabet, Ph.D, co-founder and President of Smart Approaches to Marijuana (SAM) […]

Colorado Report on High-Potency Pot is Promising; Legislators Must Act

(Denver, CO) –– Today, the Colorado School of Public Health’s Cannabis Research & Policy Project released the HB 21-1317 potency Report to the Colorado Legislature, which detailed high-potency marijuana’s harms on the state of Colorado. Last year’s regulatory overhaul law, HB1317, established a Scientific Review Council to make evidence-based recommendations to the Colorado General Assembly about regulatory changes and […]

New Federal Data Shows Marijuana is Major Factor in Emergency Department Visits Among Youth

(Washington, D.C.) – Earlier this week, preliminary data from the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Drug Abuse Warning Network (DAWN) was published for the first time since its discontinuation in 2011. DAWN is a nationwide public health surveillance system that records drug-related emergency department visit data. This year’s report, containing data collected in […]

Marijuana Legalization Vetoed by Delaware’s Governor Carney

(Dover, Delaware) Today, days after strong advocacy by SAM and its allies, Governor John Carney (D) issued a veto on House Bill 371, a bill that would have drastically expanded marijuana commercialization in the state. “This was Governor Carney’s Big Tobacco moment–and he did the right thing,” said Patrick J. Kennedy, Smart Approaches to Marijuana Co-Founder and Honorary […]

FDA Issues Warning Letters on Delta-8 THC

(Silver Spring, Maryland) Today, the Food and Drug Administration (FDA) issued several warning letters to CBD and THC companies who are illegally selling and marketing products for human and animal use containing Delta-8 tetrahydrocannabinol, also known as Delta-8 THC, and infusing them in gummi bears and other candies, pet products, oils, and other foods. Dr. Kevin […]

Largest National Coalition of Public Health, Family, Substance Use Education Groups to Oppose Developing Federal Marijuana Legalization Policy, Launch Parent Action Network

Key reasons for opposition include unregulated THC concentrations, impaired driving, youth-targeted marketing and marijuana-induced mental health concerns What: SAM to hold day long Summit at annual Rx Summit on marijuana policy issues Who: Patrick J. Kennedy; Kevin Sabet, Co-Founders of SAM; Head of Illinois NAACP Teresa Haley; Nora Volkow, Director of NIDA; Washington State Rep Lauren […]

U.S. House Passes SAM-Supported Bill Easing Access to Marijuana Research

(Washington, D.C.) – Today, the U.S. House of Representatives passed the SAM-supported Medical Marijuana Research Act. The bipartisan bill would remove some barriers that prevent researchers from adequately evaluating the potential risks and benefits of the use of marijuana and its derivatives. Notably, more than 30,000 research studies have been done on the drug under […]

MORE Act Passes House in Useless Show Vote, But Support Dwindles From Last Year

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none”][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_shadow=”none” column_border_radius=”none” column_link_target=”_self” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1/1″ tablet_width_inherit=”default” tablet_text_alignment=”default” phone_text_alignment=”default” column_border_width=”none” column_border_style=”solid” bg_image_animation=”none”][vc_column_text](Washington, D.C.) – Today, the United States House of Representatives passed the MORE Act, a bill to federally legalize and commercialize marijuana. Despite […]

President Biden’s 2023 Budget Rejects Marijuana Commercialization

(Alexandria, VA) – Sticking to campaign promises, President Biden’s new budget, released minutes ago, rejected marijuana commercialization in several major ways. It does not extend Justice Department protections to legal marijuana states, meaning federal resources can still be used to enforce marijuana laws. Additionally, the budget does not give the District of Columbia latitude to […]

U.S. Senate Passes SAM-Supported Bill Easing Access to Marijuana Research

(Washington, D.C.) – Today, the U.S. Senate passed the SAM-supported Cannabidiol Medical Marihuana Research Expansion Act. The bipartisan bill – which SAM helped to write – is sponsored by Senators Feinstein, Grassley, and Schatz, and would amend the Controlled Substances Act to remove some barriers that prevent researchers from adequately evaluating the potential risks and […]